A Dyadic Analysis of Technological Benefits Attributable to Corporate Venture Capital Ties: Evidence from the Biopharmaceutical Industry

SSRN Electronic Journal ◽

10.2139/ssrn.2429505 ◽

2014 ◽

Author(s):

Hyunsung Daniel Kang

Keyword(s):

Venture Capital ◽

Dyadic Analysis ◽

Biopharmaceutical Industry ◽

Corporate Venture Capital ◽

Corporate Venture

Download Full-text

Technology Spillovers and Capital Gains in Corporate Venture Capital: Evidence from the Biopharmaceutical Industry

SSRN Electronic Journal ◽

10.2139/ssrn.2429504 ◽

2014 ◽

Author(s):

Hyunsung Daniel Kang ◽

Vikram K. Nanda

Keyword(s):

Venture Capital ◽

Capital Gains ◽

Technology Spillovers ◽

Biopharmaceutical Industry ◽

Corporate Venture Capital ◽

Corporate Venture

Download Full-text

An Option to Ally: A Dyadic Analysis of Corporate Venture Capital Relationships

SSRN Electronic Journal ◽

10.2139/ssrn.1553322 ◽

2010 ◽

Cited By ~ 2

Author(s):

Anu Wadhwa ◽

Corey C. Phelps

Keyword(s):

Venture Capital ◽

Dyadic Analysis ◽

Corporate Venture Capital ◽

Corporate Venture

Download Full-text

Corporate Venture Capital, Competition, and Valuation in the Acquisition Market: Evidence from the Biopharmaceutical Industry

SSRN Electronic Journal ◽

10.2139/ssrn.2429508 ◽

2014 ◽

Author(s):

Hyunsung Daniel Kang ◽

Matthew John Higgins ◽

Vikram K. Nanda

Keyword(s):

Venture Capital ◽

Biopharmaceutical Industry ◽

Corporate Venture Capital ◽

Corporate Venture

Download Full-text

Technology spillovers and capital gains in corporate venture capital investments: evidence from the biopharmaceutical industry

Venture Capital ◽

10.1080/13691066.2021.1894749 ◽

2021 ◽

Vol 23 (2) ◽

pp. 129-155

Author(s):

Hyunsung D. Kang ◽

Vikram K. Nanda ◽

Haemin D. Park

Keyword(s):

Venture Capital ◽

Capital Gains ◽

Technology Spillovers ◽

Biopharmaceutical Industry ◽

Capital Investments ◽

Corporate Venture Capital ◽

Corporate Venture ◽

Venture Capital Investments

Download Full-text

Corporate Venture Capital, Technology Spillovers, and Capital Gains: Evidence from the Biopharmaceutical Industry

SSRN Electronic Journal ◽

10.2139/ssrn.2429492 ◽

2014 ◽

Author(s):

Hyunsung Daniel Kang ◽

Vikram K. Nanda

Keyword(s):

Venture Capital ◽

Capital Gains ◽

Technology Spillovers ◽

Biopharmaceutical Industry ◽

Corporate Venture Capital ◽

Corporate Venture

Download Full-text

Finanzierung durch Corporate Venture Capital und Venture Capital

10.1007/978-3-531-90273-9 ◽

2006 ◽

Cited By ~ 1

Keyword(s):

Venture Capital ◽

Corporate Venture Capital ◽

Corporate Venture

Download Full-text

The Impact of Corporate Venture Capital on the Branding Efforts of New Technology Firms

SSRN Electronic Journal ◽

10.2139/ssrn.2296402 ◽

2013 ◽

Author(s):

Ikenna S. Uzuegbunam ◽

Brandon Ofem ◽

Satish Nambisan

Keyword(s):

Venture Capital ◽

New Technology ◽

Corporate Venture Capital ◽

Technology Firms ◽

Corporate Venture ◽

The Impact

Download Full-text

The role of corporate venture capital on returns to acquiring firms: evidence from the biotechnology industry

Venture Capital ◽

10.1080/13691066.2021.1882722 ◽

2021 ◽

pp. 1-17

Author(s):

Jay J Janney ◽

Naga Lakshmi Damaraju ◽

Gregory G. Dess

Keyword(s):

Venture Capital ◽

Biotechnology Industry ◽

Corporate Venture Capital ◽

Acquiring Firms ◽

Corporate Venture

Download Full-text

Why do they do it? Corporate venture capital investments in cleantech startups

Journal of Cleaner Production ◽

10.1016/j.jclepro.2021.126315 ◽

2021 ◽

Vol 294 ◽

pp. 126315 ◽

Cited By ~ 1

Author(s):

Puck D. Hegeman ◽

Roger Sørheim

Keyword(s):

Venture Capital ◽

Capital Investments ◽

Corporate Venture Capital ◽

Corporate Venture ◽

Venture Capital Investments

Download Full-text

Technology development, severed ventures, and other aspects of corporate venture capital

10.1145/1500518.1500656 ◽

1980 ◽

Author(s):

Jean E. De Valpine

Keyword(s):

Venture Capital ◽

Technology Development ◽

Corporate Venture Capital ◽

Corporate Venture

Download Full-text